SCHEMBL4883369

SCHEMBL4883369

CC(C)(C)OC(=O)NCCC[C@@H](CNC(=O)C[C@H](CCCNC(=O)O)NC(=O)OC(C)(C)C)NC(=O)OC(C)(C)C

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.53
GAA P10253 1/20 0.53
KMT2A Q03164 1/20 0.53
TDP1 Q9NUW8 2/20 0.43
SYK P43405 1/20 0.39
MAOA P21397 1/20 0.39
MAOB P27338 1/20 0.39
CA12 O43570 2/20 0.37
CA1 P00915 2/20 0.37
CA2 P00918 2/20 0.37
CA9 Q16790 2/20 0.37
CTSK P43235 5/20 0.37
CTSS P25774 4/20 0.37
CAPN1 P07384 1/20 0.37
ATM Q13315 2/20 0.36
MAPT P10636 1/20 0.35
SIRT5 Q9NXA8 1/20 0.35
STK17B O94768 1/20 0.34
STK17A Q9UEE5 1/20 0.34
MMP1 P03956 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4883374 1.00 MEN1 (0.53) MEN1GAAKMT2ATDP1SYK
SCHEMBL5064563 0.95 MEN1 (0.53) MEN1GAAKMT2ATDP1SYK
SCHEMBL5064566 0.95 MEN1 (0.53) MEN1GAAKMT2ATDP1SYK
SCHEMBL4886861 0.93 MEN1 (0.56) MEN1GAAKMT2ATDP1SYK
SCHEMBL4888034 0.92 MEN1 (0.45) MEN1GAAKMT2ATDP1SYK
SCHEMBL4886884 0.91 MEN1 (0.49) MEN1GAAKMT2ATDP1SYK
SCHEMBL4886873 0.91 MEN1 (0.49) MEN1GAAKMT2ATDP1SYK
SCHEMBL4876370 0.90 MEN1 (0.48) MEN1GAAKMT2ATDP1SYK
SCHEMBL4888081 0.90 MEN1 (0.48) MEN1GAAKMT2ATDP1SYK
SCHEMBL4888070 0.90 MEN1 (0.48) MEN1GAAKMT2ATDP1SYK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080306040-A1 Antibacterial amide macrocycles VII AICURIS GMBH & CO. KG (DE) 2008-12-11 US disclosed
US-20080275018-A1 ANTIBACTERIAL AMIDE-MACROCYCLES V AICURIS GMBH & CO. KG (DE) 2008-11-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080275018-A1 ANTIBACTERIAL AMIDE-MACROCYCLES V ARG1, HRH3, H1-0 MEN1 1513/4885GAA 3747/4885KMT2A 1254/4885
US-20080306040-A1 Antibacterial amide macrocycles VII AADAC, AAAS, NOD2 MEN1 2121/4885GAA 260/4885KMT2A 3625/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.